GI & Endoscopy

Monthly microbiome testing and personalized probiotic subscription service Thryve closed a $1.4 million fundraising round.

Olympus launched DualKnife J, an endoscopic submucosal dissection electrosurgical knife, May 31.

GMed, a Modernizing Medicine Co., will soon become Modernizing Medicine Gastroenterology with a number of its offerings also taking on new identities later this year.

Cancer diagnostics company CellMaxLife launched Zenith, the U.S. trial of its circulating tumor cell blood test to detect colorectal cancer.

Garfield Grandison, MD, will begin seeing patients at King's Daughters Ohio in Portsmouth, the Times-Journal reports.

The International Foundation for Functional Gastrointestinal Disorders will honor four researchers for their contributions in shaping future chronic digestive disorder treatments at Digestive Disease Week, June 2 to June 5 in Washington, D.C.

Here are four updates on GI companies from the past week.

Health Union released its 2018 IBD in America survey, offering insights into inflammatory bowel disease from patients with the disease.

The American Cancer Society released new guidelines recommending 45-year-old patients get screened for colorectal cancer in response to a growing number of early-onset cases, Medscape reports.

Henry Fisher, MD, is a gastroenterologist at Burbank, Calif.-based Digestive Health Consultants.